• English
sales@copleyscientific.co.uk
+44 (0)115 961 6229
Enquire Today
  • Inhaler Testing
    • Delivered Dose Uniformity (DDU)
      • Metered-Dose Inhalers (MDIs)
      • Dry Powder Inhalers (DPIs)
      • Nebulisers
      • Aqueous Droplet Inhalers (ADIs)
      • Nasal Products
    • Ancillaries
      • Breathing Simulators
      • Flow Controllers
      • Flow Meters
      • Vacuum Pumps
      • Environmental Control
      • NGI Cooler™
      • Inhaler Testing Workstation™ (ITW)
      • Glass Expansion Chambers
      • Mouthpiece & Nosepiece Adapters
    • Special Applications
      • Abbreviated Impactor Measurement (AIM)
      • USP Monographs (Generic Drug Development)
    • Aerodynamic Particle Size Distribution (APSD)
      • Metered Dose Inhalers (MDIs)
      • Dry Powder Inhalers (DPIs)
      • Nebulisers
      • Aqueous Droplet Inhalers (ADIs)
      • Nasal Products
    • Improving IVIVCs
      • IVIVC Test Systems for DDU and APSD
      • Inhaled Dissolution
      • Facemask Testing
      • Morphology
      • Cold Freon® Effect
    • Semi-Automation
      • Automated Shake, Fire and Flow Control for MDIs, Nasal Sprays and Aerosols
      • Semi-Automation for DDU Testing
      • Semi-Automation for APSD Testing
    • APSD Data Analysis Software
      • Inhalytix®
  • Pharmaceutical Testing
    • Tablet Disintegration Testing
      • DTGi Series
    • Tablet Hardness Testing (Breaking Force)
      • Tablet Hardness Tester: TBF 100i
      • Tablet Hardness Tester: TH3
    • Suppository Testing
      • Suppository Disintegration Testing: SDT 1000
      • Vaginal Tablet Tester: VTT
    • Tablet Dissolution Testing
      • DISi Series
    • Powder Testing
      •  Tapped Density: JVi Series
      • Bulk Density: Scott Volumeter
      • Flowability: BEP2
    • Tablet Thickness Testing
      • Tablet Thickness Tester 547
      • Tablet Thickness Tester 700
      • Digital Caliper Model 500
    • Tablet Friability Testing
      • Friabimat: Coated Tablets
      • FRVi Series: Uncoated Tablets
    • Semisolids Testing
      • Vertical Diffusion Cell Test System: HDT 1000
      • Vertical Diffusion Cell Test System: HDT 1
  • Detergent Testing
    • Tergotometer
      • Tergotometer: TRG 800i
  • Resources
    • Training
    • Servicing
    • Support
    • Downloads
  • News & Events
  • About Us
    • Our History
    • Faces of Copley
    • Careers
      • Current Vacancies
      • Our Culture & Values
      • Meet Our Team
      • Why Work for Copley?
      • Our History
      • Our Office
  • Contact
    • Contact Us
    • Offices and Distributors
      • Find an Office or Distributor
      • Become a Distributor
  • Inhaler Testing
    • Delivered Dose Uniformity (DDU)
      • Metered-Dose Inhalers (MDIs)
      • Dry Powder Inhalers (DPIs)
      • Nebulisers
      • Aqueous Droplet Inhalers (ADIs)
      • Nasal Products
    • Ancillaries
      • Breathing Simulators
      • Flow Controllers
      • Flow Meters
      • Vacuum Pumps
      • Environmental Control
      • NGI Cooler™
      • Inhaler Testing Workstation™ (ITW)
      • Glass Expansion Chambers
      • Mouthpiece & Nosepiece Adapters
    • Special Applications
      • Abbreviated Impactor Measurement (AIM)
      • USP Monographs (Generic Drug Development)
    • Aerodynamic Particle Size Distribution (APSD)
      • Metered Dose Inhalers (MDIs)
      • Dry Powder Inhalers (DPIs)
      • Nebulisers
      • Aqueous Droplet Inhalers (ADIs)
      • Nasal Products
    • Improving IVIVCs
      • IVIVC Test Systems for DDU and APSD
      • Inhaled Dissolution
      • Facemask Testing
      • Morphology
      • Cold Freon® Effect
    • Semi-Automation
      • Automated Shake, Fire and Flow Control for MDIs, Nasal Sprays and Aerosols
      • Semi-Automation for DDU Testing
      • Semi-Automation for APSD Testing
    • APSD Data Analysis Software
      • Inhalytix®
  • Pharmaceutical Testing
    • Tablet Disintegration Testing
      • DTGi Series
    • Tablet Hardness Testing (Breaking Force)
      • Tablet Hardness Tester: TBF 100i
      • Tablet Hardness Tester: TH3
    • Suppository Testing
      • Suppository Disintegration Testing: SDT 1000
      • Vaginal Tablet Tester: VTT
    • Tablet Dissolution Testing
      • DISi Series
    • Powder Testing
      •  Tapped Density: JVi Series
      • Bulk Density: Scott Volumeter
      • Flowability: BEP2
    • Tablet Thickness Testing
      • Tablet Thickness Tester 547
      • Tablet Thickness Tester 700
      • Digital Caliper Model 500
    • Tablet Friability Testing
      • Friabimat: Coated Tablets
      • FRVi Series: Uncoated Tablets
    • Semisolids Testing
      • Vertical Diffusion Cell Test System: HDT 1000
      • Vertical Diffusion Cell Test System: HDT 1
  • Detergent Testing
    • Tergotometer
      • Tergotometer: TRG 800i
  • Resources
    • Training
    • Servicing
    • Support
    • Downloads
  • News & Events
  • About Us
    • Our History
    • Faces of Copley
    • Careers
      • Current Vacancies
      • Our Culture & Values
      • Meet Our Team
      • Why Work for Copley?
      • Our History
      • Our Office
  • Contact
    • Contact Us
    • Offices and Distributors
      • Find an Office or Distributor
      • Become a Distributor
Go back to News & Events

Senior appointments at Copley signal the start of a new phase of growth

03 January 2023; Nottingham, UK: Copley begins 2023 with news of key appointments to the senior team, as Jamie Clayton assumes the role of Managing Director. Known across the pharmaceutical industry for his role in propelling the FT4 Powder Rheometer to global prominence, Clayton brings complementary knowledge and widely respected expertise to the top table. Copley has also attracted Matthew Fenn to the position of Head of Business Development. With close to twenty years of experience in the healthcare sector, Fenn will focus on customer needs, advancing education and training opportunities and delivering ever more innovative product and service solutions. The appointments follow a period of sustained growth for Copley, which ended 2022 as Nottinghamshire Business of the Year winners, and reflect ambitious plans for the future.

‘Copley has grown substantially over the last five years,’ said Mark Copley, CEO ‘and we continue to welcome new recruits at all levels to augment our well-established team. Securing senior talent is an essential element of our long-term strategy but relies on identifying experienced individuals that combine a ‘Copley’ mindset with complementary and relevant experience. Both Jamie and Matthew are an ideal fit and I’m excited to begin working with them.’

As MD, Clayton will manage all day-to-day operations at Copley from finance through to product development. A primary focus will be ongoing growth of the team and embedding the company culture, to ensure optimal practice and an exceptional customer experience as expansion continues.

‘Jamie has a proven track record of company management, a customer-centric approach and in-depth technical expertise in all aspects of powder technology, from dry powder inhaler formulation to tablet manufacture,’ said Mr Copley. ‘His appointment is a major boost for Copley that will release me to explore and progress new investment opportunities and strategic partnerships, a vital element of our ongoing plans.’

Fenn joins Copley from Jabil, the world’s largest manufacturing solutions provider for the healthcare industry with experience that includes a long spell at 3M Health Care. With a background in medical devices, pharmaceutical delivery systems and consumer health products, Matthew is well-equipped to help Copley to define needs, refine services and set new goals for innovation.

‘Matthew’s key objective is to build the business development team and customer relationships that we need to drive growth,’ said Mr Copley. ‘The aim is to get closer to our customers to understand exactly what they need to succeed and how best to deliver it. Copley is growing by remaining true to our core enduring values and at the same time open to new thinking. Both Jamie and Matthew can be sure of the warmest of welcomes and an exciting time ahead.’

Mark Copley, CEO (left) welcomes Jamie Clayton (middle) as Managing Director and Matthew Fenn (right) as Head of Business Development to Copley.

About Copley Scientific
Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing.

Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products – metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays – with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals.

Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley works in partnership with specialist distributors to extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com

Previous
Contact Us Today

Have a question? Our friendly and experienced team are here to help.

T: +44 (0)115 961 6229 E: sales@copleyscientific.co.uk
Contact Us
Please review our privacy policy so you understand how we collect and use your personal data.
reCAPTCHA
Quality Logos
  • Contact
  • News & Events
  • Downloads
  • Privacy Policy
  • Anti-Bribery Policy
  • Terms and Conditions
  • Join Our Mailing List
Copley Scientific Limited, Colwick Quays Business Park, Road No. 2, Nottingham, NG4 2JY, United Kingdom
+44 (0)115 961 6229 +44 (0)115 961 7637 sales@copleyscientific.co.uk
© 2023 Copley Scientific Limited. Website by Fifteen
  • English